rs3733591
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common in clinvar |
Make rs3733591(A;A) |
Make rs3733591(A;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 4 |
Position | 9920506 |
Gene | SLC2A9 |
is a | snp |
is | mentioned by |
dbSNP | rs3733591 |
dbSNP (classic) | rs3733591 |
ClinGen | rs3733591 |
ebi | rs3733591 |
HLI | rs3733591 |
Exac | rs3733591 |
Gnomad | rs3733591 |
Varsome | rs3733591 |
LitVar | rs3733591 |
Map | rs3733591 |
PheGenI | rs3733591 |
Biobank | rs3733591 |
1000 genomes | rs3733591 |
hgdp | rs3733591 |
ensembl | rs3733591 |
geneview | rs3733591 |
scholar | rs3733591 |
rs3733591 | |
pharmgkb | rs3733591 |
gwascentral | rs3733591 |
openSNP | rs3733591 |
23andMe | rs3733591 |
SNPshot | rs3733591 |
SNPdbe | rs3733591 |
MSV3d | rs3733591 |
GWAS Ctlg | rs3733591 |
GMAF | 0.2938 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
[PMID 19723617] Associations of a nonsynonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese and Solomon Islanders
[PMID 21658257] The SLC2A9 non-synonymous Arg265His variant and gout; evidence for a population-specific effect on severity
[PMID 18759275] Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish.
[PMID 25867401] Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population
[PMID 27511497] Association analysis of five SNP variants with gout in the Minnan population in China.
ClinVar | |
---|---|
Risk | rs3733591(A;A) |
Alt | rs3733591(A;A) |
Reference | Rs3733591(G;G) |
Significance | Non-pathogenic |
Disease | Familial renal hypouricemia |
Variation | info |
Gene | SLC2A9 |
CLNDBN | Familial renal hypouricemia |
Reversed | 1 |
HGVS | NC_000004.11:g.9922130C>T |
CLNSRC | |
CLNACC | RCV000317105.1, |
[PMID 30350810] Association of solute carrier family 2, member 9 (SLC2A9) genetic variant rs3733591 with gout in a Malay sample set.
[PMID 32183743] ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.